
NLS Pharma
Treatments for attention deficit hyperactivity disorder and other neurological disorders.
Market cap
$10.8m
Enterprise value
$12m
Share price
$2.20 NLSP
Company register number
CHE-348.607.509
Authorizing premium user...
Treatments for attention deficit hyperactivity disorder and other neurological disorders.